BORSARI, CHIARA

BORSARI, CHIARA  

Dipartimento di Scienze Farmaceutiche  

Mostra records
Risultati 1 - 20 di 49 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα 2024 Borsari, Chiara + Article (author) -
Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond 2024 Borsari, Chiara + Article (author) -
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antiradical and antimicrobial agents 2024 Sara VicinanzaLara MombelliFrancesca AnnunziataSilvia DonzellaMartina Letizia ContenteChiara BorsariPaola ContiGabriele MeroniFrancesco MolinariPiera Anna MartinoAndrea PintoLucia Tamborini Article (author) -
Chemo-enzymatic flow synthesis of tyrosol and hydroxytyrosol carbonates and carbamates as novel antiradical and antimicrobial agents 2023 SARA VICINANZAFrancesca AnnunziataLara MombelliDesiree PecoraSilvia DonzellaMartina Letizia ContenteGabriele MeroniValerio Massimo SoraPiera Anna MartinoChiara BorsariAndrea PintoLucia Tamborini Conference Object -
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 2023 Galbiati, AndreaBorsari, ChiaraConti, Paola + Article (author) -
Stereospecific Synthesis of Substituted Sulfamidates as Privileged Morpholine Building Blocks 2023 Borsari C. + Article (author) -
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange 2023 Borsari C. + Article (author) -
The Facets of Diversity: The EFMC Perspective 2023 Borsari, Chiara + Article (author) -
Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives 2023 Galbiati, AndreaBorsari, ChiaraCorfu, Alexandra IoanaTamborini, LuciaBasilico, NicolettaParapini, SilviaConti, Paola + Article (author) -
Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor 2023 Borsari, Chiara + Article (author) -
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange 2023 Borsari C. + Article (author) -
Understanding Intrinsic Warhead Reactivity and Cysteine Druggability in Covalent Drug Discovery 2023 Borsari, CCorfu, ALConti, P Article (author) -
Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα 2022 Borsari C. + Article (author) -
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K 2022 Borsari C + Patent -
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS 2022 Borsari C + Patent -
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K 2022 Borsari C + Patent -
Two-drug trick to target the brain blocks toxicity in the body 2022 Borsari, Chiara + Article (author) -
Disease related mutations in PI3Kgamma disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors 2021 Chiara Borsari + Article (author) -
Chemical and Structural Strategies to Selectively Target mTOR Kinase 2021 Borsari C. + Article (author) -
Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability 2021 Borsari C. + Article (author) -